Main Menu

Organogenesis Holdings Inc.

(NASDAQ CM: ORGO)

Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Organogenesis Holdings Inc. ("Organogenesis") on behalf of stockholders.  A class action complaint has been filed against Organogenesis, which alleges that defendants made materially false and misleading statements regarding Organogenesis's business, operations, and prospects. Specifically, the complaint alleges that: (i) Organogenesis improperly billed the federal government for its Affinity and PuraPly XT products by, among other things, setting the price for those products multiple times higher than similar products; (ii) Organogenesis improperly induced doctors to use its Affinity and PuraPly XT products through lucrative reimbursements; (iii) as a result, Organogenesis's revenue and profits derived from its Affinity and PuraPly XT products were at least in substantial part unsustainable; and (iv) accordingly, Organogenesis's public statements were materially false and misleading at all relevant times.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 05/18/2022


* Indicates a required field.

Back to Page